Wockhardt Ltd. is a global pharmaceutical and biotechnology organisation, providing affordable, high-quality medicines for a healthier world. It is India’s leading research-based global healthcare enterprise with relevance in the fields of Pharmaceuticals, Biotechnology and a chain of advanced Super Speciality Hospitals. It is a true Indian Multi-National Company with a multi-ethnic workforce of many Wockhardt Associates from many different nationalities globally. It has many research centres and several manufacturing plants, with businesses ranging from the manufacture and marketing of Pharmaceutical and Bio-pharmaceutical formulations, Active Pharmaceutical Ingredients (APIs) and Vaccines. It is a business in transition. New and innovative business models are in motion to make the most of emerging opportunities. A new drive for growth today permeates every mind-set, process and techno-innovation within Wockhardt.

Business area of the company

The company is a pharmaceutical and biotechnology company. The Company's businesses include manufacture and marketing of pharmaceutical and bio-pharmaceutical formulations, active pharmaceutical ingredients (APIs) and vaccines.

Wockhardt Ltd.

Indoco Remedies Ltd.

Shilpa Medicare Ltd.

Advanced Enzyme Technologies Ltd.

Unichem Laboratories Ltd.

Hikal Ltd.

IOL Chemicals And Pharmaceuticals Ltd.

Gufic Biosciences Ltd.

Dishman Carbogen Amcis Ltd.

Orchid Pharma Ltd.

Supriya Lifescience Ltd.

Strides Pharma Science Ltd.

Sequent Scientific Ltd.

RPG Life Sciences Ltd.

Neuland Laboratories Ltd.

Open Price	231.8	Volume	27,182
Prev. Close	231.8

Performance